Related Experiment Video
Updated: May 17, 2025

00:09
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
21.5K
Genome-Wide CRISPR Screening Identifies Cellular Factors Controlling Nonviral Genome Editing Efficiency
Biorxiv : the Preprint Server for Biology
|March 31, 2025
Summary
Researchers developed a genome-wide CRISPR screen to identify genes enhancing genome editing efficiency. Knocking out six identified genes boosted nonviral editing up to five-fold in human cells, paving the way for improved gene therapy delivery.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Genome editing efficiency is hindered by cellular uptake, trafficking, and nuclear import barriers.
- These barriers vary significantly based on cell type and vector characteristics, such as lipid nanoparticles.
Purpose of the Study:
- To develop a genome-wide CRISPR screening strategy to identify genes that modulate cellular uptake, payload delivery, and gene editing efficiency in human cells.
- To uncover novel targets for enhancing nonviral genome editing delivery methods.
Main Methods:
- A genome-wide CRISPR screen targeting 19,114 genes in HEK293 cells was performed.
- Cas-based nuclease and base editing strategies were employed to interrogate cellular processes controlling genome editing.
- Short-read sequencing was used to track guide RNA identity and editing outcomes, enabling computational sorting of edited and unedited cells.
Main Results:
- Six genes were identified whose knockout increased nonviral editing efficiency by up to five-fold in human cells.
- Arrayed knockouts of top hits enhanced Cas9 editing efficiency from 5% to 50% using lipid-based nanoparticles.
- Knockouts of BET1L, GJB2, and MS4A13 genes increased targeted genome editing by over five-fold in patient-derived retinal pigment epithelium cells.
Conclusions:
- The high-throughput screening approach successfully identified key genes modulating nonviral genome editing efficiency.
- The identified genes can be leveraged to engineer improved nonviral delivery methods for gene editing.
- This strategy holds potential for enhancing genome editing efficiency in various therapeutically relevant cell types.
Related Concept Videos
CRISPR
48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K
CRISPR and crRNAs
16.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.4K
Homologous Recombination
49.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
49.9K

